Listing 1 - 9 of 9 |
Sort by
|
Choose an application
Research on, and interest in, red blood cell formation spans several centuries and was thought to have peaked in the 1980s with the cloning of the eryth- poietin (EPO) gene. In the years subsequent to the cloning of EPO and its expression as a recombinant protein, much was written about EPO. Although much has been learned and published, new, exciting data are becoming ava- able on almost a daily basis. Erythropoietins and Erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology compiles both pertinent historical and very recent research on this molecule and its clinical utility. The book is divided into two sections: Background and Basic Science and Clinical Uses of Recombinant Erythropoietins. To begin, Israels and Israels describe the biology of red cells, the hierarchy of erythropoietic progenitor cells, their development to mature cells, and the effects of endogenous EPO on their development. Foote summarizes the historical interest in, and search for, an erythropoietic factor. Once EPO was identified,cloned,and expressed,the path was set for the study of other aspects of EPO biology both within e- thropoiesis and other cellular systems.
Anemia. --- Erythropoiesis. --- Erythropoietin. --- Recombinant erythropoietin. --- Erythropoiesis --- Erythropoietin --- Recombinant erythropoietin --- Anemia --- Physiology --- Human Anatomy & Physiology --- Health & Biological Sciences --- Hematopoiesis --- Colony-Stimulating Factors --- Hematopoietic Cell Growth Factors --- Glycoproteins --- Cell Differentiation --- Blood Physiological Processes --- Blood Physiological Phenomena --- Proteins --- Cell Physiological Processes --- Cytokines --- Cell Physiological Phenomena --- Circulatory and Respiratory Physiological Phenomena --- Amino Acids, Peptides, and Proteins --- Intercellular Signaling Peptides and Proteins --- Peptides --- Phenomena and Processes --- Chemicals and Drugs --- Biological Factors --- Treatment --- Treatment. --- Anaemia --- Epoetin --- Epogen (Trademark) --- Genetically engineered erythropoietin --- Genetic engineering --- Medicine. --- Pharmacology. --- Endocrinology. --- Sports medicine. --- Cell biology. --- Biomedicine. --- Pharmacology/Toxicology. --- Cell Biology. --- Sports Medicine. --- Blood --- Recombinant blood proteins --- Colony-stimulating factors (Physiology) --- Hematopoietic growth factors --- Diseases --- Toxicology. --- Cytology. --- Chemicals --- Medicine --- Pharmacology --- Poisoning --- Poisons --- Athletic medicine --- Athletics --- Medicine and sports --- Physical education and training --- Sports --- Sports sciences --- Cell biology --- Cellular biology --- Biology --- Cells --- Cytologists --- Internal medicine --- Hormones --- Toxicology --- Medical aspects --- Endocrinology . --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemotherapy --- Drugs --- Pharmacy --- Physiological effect
Choose an application
Erythropoietin and the Nervous System is the first book of its kind to bring together researchers from many different disciplines of neuroscience to present a current state-of-the-art review of multiple aspects of erythropoietin research as it relates to the nervous system. Erythropoietin (EPO) is a chemokine hormone that is widely distributed throughout the body. In addition to its traditional role as a hormone that stimulates red blood cell production, in recent years many laboratories have shown that EPO can act as a neuroprotective compound in a variety of injury paradigms in the nervous system. Past experience with the relatively safety profile of this FDA-approved drug makes it an ideal candidate to take into clinical trials for neuroprotection. We are on the verge of major clinical trials using this drug for neuroprotection in diseases ranging from stroke, to transverse myelitis to chemotherapy-induced peripheral neuropathy. This book should stimulate new research on erythropoietin and the nervous system and bring new investigators to the field. It will benefit scientists and clinicians interested in neuroprotection in the broadest sense.
Erythropoietin --- Physiological aspects. --- Colony-stimulating factors (Physiology) --- Hematopoietic growth factors --- Neurology. --- Neurosciences. --- Psychiatry. --- Neurosurgery. --- Nerves --- Neurosurgery --- Medicine and psychology --- Mental health --- Psychology, Pathological --- Neural sciences --- Neurological sciences --- Neuroscience --- Medical sciences --- Nervous system --- Medicine --- Neuropsychiatry --- Surgery --- Diseases --- Neurology .
Choose an application
Anemia is a frequent complication of cancer and its treatment. It produces many symptoms and significantly impairs metabolic and physiologic functions as well as patients' activity, well-being and quality of life. Life expectancy is also affected. This book, now being published in its second edition, comprehensively presents the current knowledge on anemia in cancer and its treatment with rhEPO. Future developments are also discussed. Based on updated and new chapters, including a broader spectrum of topics, outstanding international experts describe the scientific and clinical aspects of anemia in various fields of oncology and give diagnostic and therapeutic recommendations on when and how to use rhEPO. The book, considered as a standard work, will again serve as an essential source of information for radiotherapists, medical oncologists, hematologists, internists, pediatricians, surgeons, specialists in transfusion and laboratory medicine, and pharmacologists.
Medicine & Public Health. --- Oncology. --- Radiotherapy. --- Hematology. --- Surgery. --- Pharmacology/Toxicology. --- Blood Transfusion Medicine. --- Medicine. --- Toxicology. --- Blood transfusion. --- Médecine --- Toxicologie --- Radiothérapie --- Hématologie --- Cancérologie --- Chirurgie --- Anemia -- Chemotherapy. --- Antineoplastic agents. --- Cancer -- Chemotherapy -- Complications -- Chemotherapy. --- Drug Design. --- Drug Therapy. --- Recombinant erythropoietin -- Therapeutic use. --- Recombinant erythropoietin --- Anemia --- Cancer --- Colony-Stimulating Factors --- Hematologic Diseases --- Diseases --- Hemic and Lymphatic Diseases --- Hematopoietic Cell Growth Factors --- Glycoproteins --- Erythropoietin --- Neoplasms --- Cytokines --- Proteins --- Intercellular Signaling Peptides and Proteins --- Amino Acids, Peptides, and Proteins --- Chemicals and Drugs --- Peptides --- Biological Factors --- Medicine --- Health & Biological Sciences --- Oncology --- Therapeutic use --- Chemotherapy --- Complications --- Therapeutic use. --- Chemotherapy. --- Cancers --- Carcinoma --- Malignancy (Cancer) --- Malignant tumors --- Anaemia --- Epoetin --- Epogen (Trademark) --- Genetically engineered erythropoietin --- Genetic engineering --- Pharmacology. --- Tumors --- Blood --- Recombinant blood proteins --- Oncology . --- Blood transfusion --- Blood transfusion therapy --- Hemotherapy --- Transfusion medicine --- Transfusion of blood --- Transfusion therapy --- Transfusion therapy, Blood --- Surgery --- Blood banks --- Blood groups --- Hospitals --- Transfusion-free surgery --- Chemicals --- Pharmacology --- Poisoning --- Poisons --- Surgery, Primitive --- Haematology --- Internal medicine --- Radiation therapy --- Electrotherapeutics --- Medical electronics --- Medical radiology --- Therapeutics, Physiological --- Phototherapy --- Transfusion committees --- Toxicology --- Radiological services --- Drug effects --- Medical pharmacology --- Medical sciences --- Drugs --- Pharmacy --- Physiological effect
Choose an application
This second edition is a one-source guide to current information about red blood cell physiology and the action of native and recombinant human erythropoietic factors. Topics in the fields of erythropoiesis, recombinant protein discovery and production, and treatment of patients with anemia due to renal failure, cancer, or chronic diseases are covered. The newest theories in erythropoiesis (receptors, signaling), manufacturing, new formulations, and clinical research are discussed. This book is of interest to researchers and clinical investigators in academia and biotechnology and pharmaceutical companies, to clinical research associates, clinical monitors, and physician investigators.
Anemia --Treatment. --- Erythropoiesis --Molecular aspects. --- Erythropoiesis. --- Erythropoietin --Therapautic use. --- Erythropoietin. --- Erythropoietin --- Erythropoiesis --- Anemia --- Drug Therapy --- Erythropoietin, Recombinant --- Pharmacology --- Colony-Stimulating Factors --- Therapeutics --- Hematopoiesis --- Hematologic Diseases --- Biological Science Disciplines --- Recombinant Proteins --- Blood Physiological Processes --- Hemic and Lymphatic Diseases --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Hematopoietic Cell Growth Factors --- Proteins --- Cell Differentiation --- Natural Science Disciplines --- Glycoproteins --- Amino Acids, Peptides, and Proteins --- Blood Physiological Phenomena --- Diseases --- Cell Physiological Processes --- Cytokines --- Disciplines and Occupations --- Intercellular Signaling Peptides and Proteins --- Chemicals and Drugs --- Cell Physiological Phenomena --- Circulatory and Respiratory Physiological Phenomena --- Phenomena and Processes --- Peptides --- Biological Factors --- Pharmacy, Therapeutics, & Pharmacology --- Physiology --- Health & Biological Sciences --- Human Anatomy & Physiology --- Therapeutic use --- Molecular aspects --- Treatment --- Therapeutic use. --- Molecular aspects. --- Treatment. --- Anaemia --- Medicine. --- Pharmacology. --- Endocrinology. --- Sports medicine. --- Cell biology. --- Biomedicine. --- Pharmacology/Toxicology. --- Cell Biology. --- Sports Medicine. --- Blood --- Molecular biology --- Colony-stimulating factors (Physiology) --- Hematopoietic growth factors --- Toxicology. --- Cytology. --- Internal medicine --- Hormones --- Athletic medicine --- Athletics --- Medicine and sports --- Physical education and training --- Sports --- Medicine --- Sports sciences --- Cell biology --- Cellular biology --- Biology --- Cells --- Cytologists --- Chemicals --- Poisoning --- Poisons --- Medical aspects --- Toxicology --- Endocrinology . --- Drug effects --- Medical pharmacology --- Medical sciences --- Chemotherapy --- Drugs --- Pharmacy --- Physiological effect
Choose an application
Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection constitute the standard treatment for non-muscle invasive or very high-risk non-muscle invasive bladder cancer, respectively. However, survival expectations have not shown to improve in the last 20 years, and new diagnostic and therapeutic tools are urgently needed to improve the outcomes of this potentially lethal disease.
iron deficiency anemia --- fermented goat milk --- brain molecular functions --- neuroprotective effect --- iron supplementation --- pregnancy --- randomized controlled trial --- serum ferritin --- hemoglobin --- iron status --- iron stores --- HFE gene --- iron --- anemia --- kidney --- hepcidin --- erythropoietin --- celiac disease --- gluten-free diet --- iron deficiency --- micronutrient deficiencies --- infant --- breast milk --- formula milk --- high intensity exercise --- ubiquinol --- hematological parameters --- inflammation --- ergogenic effect --- acai --- erythropoiesis --- anaemia --- altitude adjustment --- haemoglobin --- South Africa --- women of reproductive age --- nutritional adequacy --- children --- fermented cow and goat milk --- iron homeostasis --- iron repletion --- gene and protein expression --- redox unbalance --- prematurity --- transfusion --- blood-sparing
Choose an application
This book outlines some new advances in genetics, clinical evaluation, localization, therapy (newly including immunotherapy) of pheochromocytoma and paraganglioma including their metastatic counterparts. Well-known and experienced clinicians and scientists contributed to this book to include some novel approaches to these tumors. This book will serve to various health care professionals from different subspecialties, but mainly oncologists, endocrinologists, endocrine surgeons, pediatricians, and radiologists. This book shows that the field of pheochromocytoma/paraganglioma is evolving and a significant progress has been made in last 5 years requiring that health care professionals and scientists will learns new information and implement it in their clinical practice or scientific work, respectively. This book should not be missed by anybody who is focusing on neuroendocrine tumors, their newest evaluation and treatment.
polycythemia --- peptide receptor radiotherapy --- n/a --- vasculogenesis --- catecholamines --- neuroendocrine --- GTV --- adaptive immunity --- therapy resistance --- histology --- transgenic mice --- cryoablation --- spheroids --- energy metabolism --- somatostatinoma --- angiogenesis --- pheochromocytoma --- SDHD --- percutaneous ethanol injection --- metanephrines --- SDHB --- global longitudinal strain --- mutation --- normetanephrines --- catecholamine --- PASS --- PGL --- 177Lu-DOTATATE --- chromosomal alteration --- speckle-tracking echocardiography --- lL-6 --- dog --- percutaneous ablation --- stem-like tumor cells --- EPAS1 --- neural crest --- fluorescence imaging --- neutrophil --- xenograft --- inflammation --- head and neck --- weighted standard deviation --- FGF21 --- calorimetry --- HIF --- average real variability --- next-generation sequencing --- adrenocortical carcinoma --- carotid body --- hypoxia-inducible factor --- paraganglioma --- succinate dehydrogenase --- blood pressure variability --- arrhythmia --- mortality --- NF1 --- toll-like receptor --- GAPP --- NET --- subclinical systolic dysfunction --- pheochromocytoma and paraganglioma --- PET-CT --- pan-cancer analysis --- mouse pheochromocytoma cells --- innate immunity --- neurogenesis --- neuroendocrine tumor --- obesity --- hypotension --- hypoxia --- CNV detection --- 18F-FDOPA --- comparative genomics --- adrenomedullary function --- PCC --- pathogen-associated molecular patterns --- adrenal tumor --- radiotherapy --- 11C-hydroxy-ephedrine --- radiofrequency ablation --- PPGL --- minimally invasive procedure --- sporadic --- diabetes mellitus --- adrenal incidentaloma --- germline mutation --- immunotherapy --- VHL --- immunohistochemistry --- metastatic OR malignant pheochromocytoma --- erythropoietin --- postoperative --- targeted therapy --- PRRT --- metastatic --- mitochondria --- T cell --- TCA cycle --- meta-analysis --- pseudohypoxia --- ectopic secretion --- radiosensitization --- chromogranin A --- hereditary --- hypertension --- PET --- phosphorylation tyrosine hydroxylase
Choose an application
In this book, the emphasis is on various training interventions. Types of exercises that can help improve performance in athletes and health in people facing poor movement diseases.Also, we have presented a variety of strength training interventions in the form of various types of research. On the other hand, we continue to monitor internal and external loads related to non-contact injuries and performance analysis.
Humanities --- Social interaction --- COVID-19 --- immune response --- chronic diseases --- exercise --- oxidative stress --- anti-inflammatory treatment --- fibroblast growth factor 21 --- cytokines --- myokines --- anabolic–androgenic steroids --- athletes --- baroreflex sensitivity --- cardiac autonomic nervous system --- cardiac function --- physical guidance --- tracking task --- cerebral palsy --- challenge point framework --- frequency --- virtual driving --- physical activity --- behavioral status --- mental state --- older men --- reaction time --- visual coordination --- visual reaction --- female --- football --- autonomic modulation --- fatigue --- training load --- altitude --- haemoglobin --- erythropoietin --- hypoxia --- endurance --- sand --- occupational health --- tactical athlete --- landing error scoring system --- reactive strength index --- tactical personnel --- force plates --- military --- law enforcement --- neuromuscular fatigue --- spinal curvature --- Paralympic volleyball --- compensation strategy --- thoracic hyperkyphosis --- adapted training --- low back pain --- kidney failure --- AKI --- health --- biomarkers --- strenuous exercise --- mountain running --- kidney function --- off-road running --- performance --- kinematics --- laser --- computer vision --- inertial device --- IMU --- injury risk --- high load --- external monitoring --- high-speed distance --- global positioning system --- movement analysis --- handball shot --- internal load --- shot precision --- motor decisions-making --- GPS --- T-Patterns --- acceleration --- motor praxeology --- role --- anatomy --- spine --- thoracic spine --- low back --- lumbar spine --- biomechanics --- rowing --- antioxidant status --- nutrition --- reactive oxygen species (ROS) --- biomechanical analysis --- pressure insoles --- Xsens motion capture system --- performance analysis --- recreational skiers --- dry-land training --- GEE modeling --- oxygen consumption --- strength training --- surface electromyography --- bone mineral --- skeletomuscular robusticity --- elite athletes --- DEXA --- executive functions --- shooting performance --- gender differences --- cadets --- resistance training --- power exercise --- team sport --- conditioning capabilities --- lower extremity --- dynamic balance --- dose–response --- training intensity --- elastic bands --- chain --- eccentric training --- decline squat --- patellar tendon --- sonoelastography --- stiffness
Choose an application
The concept of mechanism in biology has three distinct meanings. It may refer to a philosophical thesis about the nature of life and biology, to the internal workings of a machine-like structure, or to the causal explanation of a particular phenomenon. In this Special Issue, we try to discuss these possible biological mechanisms that underlie the beneficial effects of physical fitness and sports performance, as well their importance and role/influences on physical health.Despite the significant body of knowledge regarding the physiological and physical effects of different training methods (based on dimensions of load), some of the biological causes for those changes are still unknown. Additionally, few studies have focused on the natural biological variability in humans and how specific properties of humans may justify different effects for the same training intervention. Thus, more original research is needed to provide plausible biological mechanisms that may explain the physiological and physical effects of exercise and training in humans.In this Special Issue, we gather the contributions that describe and list the links between physical fitness, sports performance, and human biology.
Research & information: general --- Biology, life sciences --- body composition --- BIVA --- fat mass --- weight loss --- HRQoL --- knowledge --- physical activity --- rheumatic diseases --- women --- 25(OH)D --- physiology of performances --- puberty --- pre-planned agility --- non-planned agility --- Paralympic Powerlifting --- ibuprofen --- muscle strength --- oxidative stress --- recovery of function --- satellite cells --- muscle regeneration --- myogenic regulatory factors --- inflammation --- exercise --- age --- athletic performance --- rowing --- sport --- young athlete --- mathematical model --- executive functions --- cognitive performance --- youth --- physical education --- BIA --- coronavirus disease --- detraining --- football --- muscle mass --- team sports --- soccer --- high-intensity --- small-sided games --- psychophysiological responses --- combined training --- cycling --- endurance --- oxygen uptake --- FTP --- threshold --- power --- strength --- muscular activity --- electromyography --- core endurance test --- muscular performance --- erythropoietin --- erythroferrone --- mental health --- sports --- spinal cord injury --- resistance training --- muscle damage --- acid–base balance --- kickboxing --- metabolic acidosis --- type 2 diabetes --- physical exercise --- high-intensity interval training --- cardiac autonomic modulation --- heart rate recovery --- heart rate variability --- aerobic training --- health --- triathlon --- performance --- ergogenic aids --- muscle fatigue --- recovery --- hormones --- antioxidant --- body fat --- IgA --- immunomodulation --- nutritional supplement --- obesity --- vibrating exercise equipment --- chronic low back pain --- surface electromyography --- biological mechanisms --- physical health --- sports and exercise physiology --- glucagon-like peptide-1 --- glucose-dependent insulinotropic polypeptide --- dry land training --- one repetition maximum --- back squat --- water parachute --- aquatic training --- swimming performance --- hypoxic dose --- muscular endurance --- sex difference --- flanker --- adolescent --- Tabata training --- blood pressure --- cardiorespiratory fitness --- physical education lessons --- log-linear analysis --- multivariate correspondence analysis --- load --- heart rate --- high-speed running --- monotony --- muscle soreness --- sprint --- sleep --- strain --- stress --- tumour --- depression --- cancer survivorship --- cardiovascular fitness --- aerobic capacity --- skin surface temperature --- high-intensity exercise --- thermal imaging --- acute exercise --- hormonal response --- saliva --- strength training --- lean body mass --- kinanthropometry --- n/a --- acid-base balance
Choose an application
In recent years, artificial intelligence has increasingly been playing an essential role in diverse areas in medicine, assisting clinicians in patient management. In nephrology and transplantation, artificial intelligence can be utilized to enhance clinical care, such as through hemodialysis prescriptions and the follow-up of kidney transplant patients. Furthermore, there are rapidly expanding applications and validations of comprehensive, computerized medical records and related databases, including national registries, health insurance, and drug prescriptions. For this Special Issue, we made a call to action to stimulate researchers and clinicians to submit their invaluable works and present, here, a collection of articles covering original clinical research (single- or multi-center), database studies from registries, meta-analyses, and artificial intelligence research in nephrology including acute kidney injury, electrolytes and acid–base, chronic kidney disease, glomerular disease, dialysis, and transplantation that will provide additional knowledge and skills in the field of nephrology and transplantation toward improving patient outcomes.
tacrolimus --- C/D ratio --- tacrolimus metabolism --- everolimus --- conversion --- kidney transplantation --- gut microbiome --- renal transplant recipient --- diarrhea --- immunosuppressive medication --- gut microbiota --- 16S rRNA sequencing --- butyrate-producing bacteria --- Proteobacteria --- torquetenovirus --- immunosuppression --- transplantation --- immunosuppressed host --- outcome --- renal transplantation --- Goodpasture syndrome --- anti-GBM disease --- epidemiology --- hospitalization --- outcomes --- acute kidney injury --- risk prediction --- artificial intelligence --- patent ductus arteriosus --- conservative management --- blood pressure --- eradication --- interferon-free regimen --- hepatitis C infection --- kidney transplant --- allograft steatosis --- lipopeliosis --- transplant numbers --- live donors --- public awareness --- Google TrendsTM --- machine learning --- big data --- nephrology --- chronic kidney disease --- NLR --- PLR --- RPGN --- predictive value --- hemodialysis --- withdrawal --- cellular crescent --- global sclerosis --- procurement kidney biopsy --- glomerulosclerosis --- minimally-invasive donor nephrectomy --- robot-assisted surgery --- laparoscopic surgery --- organ donation --- living kidney donation --- MeltDose® --- LCPT --- renal function --- liver transplantation --- metabolism --- erythropoietin --- fibroblast growth factor 23 --- death --- weekend effect --- in-hospital mortality --- comorbidity --- dialysis --- elderly --- klotho --- α-Klotho --- FGF-23 --- kidney donor --- Nephrology --- CKD-MBD --- CKD-Mineral and Bone Disorder --- deceased donor --- Eurotransplant Senior Program --- risk stratification --- intensive care --- kidney transplant recipients --- long-term outcomes --- graft failure --- cardiovascular mortality --- lifestyle --- inflammation --- vascular calcification --- bone mineral density --- dual-energy X-ray absorptiometry --- living donation --- repeated kidney transplantation --- graft survival --- prolonged ischaemic time --- patient survival --- pre-emptive transplantation --- metabolomics --- urine --- acute rejection --- allograft --- cystatin C --- hyperfiltration --- kidney injury molecule (KIM)-1 --- tubular damage --- genetic polymorphisms --- (cardiac) surgery --- inflammatory cytokines --- clinical studies --- chronic kidney disease (CKD) --- no known kidney disease (NKD) --- ICD-10 billing codes --- phenotyping --- electronic health record (EHR) --- estimated glomerular filtration rate (eGFR) --- machine learning (ML) --- generalized linear model network (GLMnet) --- random forest (RF) --- artificial neural network (ANN), clinical natural language processing (clinical NLP) --- discharge summaries --- laboratory values --- area under the receiver operating characteristic (AUROC) --- area under the precision-recall curve (AUCPR) --- fibrosis --- extracellular matrix --- collagen type VI --- living-donor kidney transplantation --- ethnic disparity
Listing 1 - 9 of 9 |
Sort by
|